Quarterly ResultAug 5, 2026, 06:13 AM
ICL Group Q2 Sales Up 17% to $2.1B; Adj. EBITDA Up 28% to $448M
AI Summary
ICL Group reported strong Q2 2026 financial results with sales up 17% to $2.1 billion, adjusted EBITDA up 28% to $448 million, and adjusted net income increasing 35% to $149 million, resulting in adjusted diluted EPS of $0.12. The company announced a new division structure effective 2027, reorganizing around end markets, and launched the "Elevate" cost transformation program aiming for over $350 million in additional EBITDA by the end of 2028. ICL Group also reiterated its FY 2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion and Potash sales volumes guidance of 4.5 Mmt to 4.7 Mmt.
Key Highlights
- Q2 2026 total sales increased 17% year-over-year to $2.1 billion.
- Q2 2026 adjusted EBITDA rose 28% year-over-year to $448 million.
- Q2 2026 adjusted net income grew 35% to $149 million, with adjusted diluted EPS at $0.12.
- Launched "Elevate" cost transformation program targeting over $350 million in additional EBITDA by end of 2028.
- New division structure effective 2027, organizing around end markets: Nutrition Solutions, Industrial Products, Essential Minerals, and Growing Solutions.
- Reiterated FY 2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion.
- Reiterated FY 2026 Potash sales volumes guidance of 4.5 Mmt to 4.7 Mmt.
Price Impact
More from ICL